UMMS Affiliation

Laboratory of Nucleic Acid Vaccines, Department of Medicine

Publication Date

2020-03-08

Document Type

Article

Disciplines

Immunology of Infectious Disease | Immunoprophylaxis and Therapy | Immunotherapy | Infectious Disease | Microbiology | Virus Diseases

Abstract

The rapidly emerging SARS-2-CoV (SARS-2) has been spreading through China and entering many parts of the world with easy human-to-human transmission and thousands of deaths. Development of a vaccine, and a vaccine which can be quickly deployed on a global scale, is no longer merely a discussion or part of a debate whether such a vaccine is ultimately needed.

Keywords

SARS-2-CoV, SARS-2, vaccines, vaccination, 2019-nCoV, COVID-19

Rights and Permissions

© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor and Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

DOI of Published Version

10.1080/22221751.2020.1737580

Source

Emerg Microbes Infect. 2020 Dec;9(1):542-544. doi: 10.1080/22221751.2020.1737580. Link to article on publisher's site

Journal/Book/Conference Title

Emerging microbes and infections

Related Resources

Link to Article in PubMed

PubMed ID

32148172

Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS